July 2, 2010
Shanghai, China
Finnegan partners Rich Racine, Esther Lim, and Ningling Wang will present on "Preparing and Prosecuting U.S. Patent Applications to Obtain USFDA Orange Book Listed Patents," "Surviving Bilski: Strategies for Biopharm Companies," and "Recent Developments of Biosimilars in the U.S.," at the Advanced Intellectual Property Seminar Series on "U.S. Patent Litigation for Chinese Companies." The seminar will take place at the Shangri-la Pudong in Shanghai, China. To register, please send an email to ipeventshanghai@finnegan.com.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.